Epigenetics, fragile X syndrome and transcriptional therapy, Am. J. Med. Genet. A, vol.161, issue.11, pp.2797-2808, 2013. ,
Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system, Cardiovasc. Res, vol.43, issue.4, pp.985-991, 1999. ,
Are epigenetic drugs for diabetes and obesity at our door step?, Drug Discov. Today, vol.21, issue.3, pp.499-509, 2016. ,
Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy, Sci. Rep, vol.7, issue.1, p.4035, 2017. ,
FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension, Oncologist, vol.10, issue.3, pp.176-182, 2005. ,
, ? Reports the interest to use DNA methyltransferase inhibitors in anticancer therapy
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a Phase III randomized study, Cancer, vol.106, issue.8, pp.1794-1803, 2006. ,
Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation, Nucleic Acids Res, vol.35, issue.13, pp.4301-4312, 2007. ,
Dissection of cell cycle-dependent dynamics of Dnmt1 by FRAP and diffusion-coupled modeling, Nucleic Acids Res, vol.41, issue.9, pp.4860-4876, 2013. ,
Kinetics of DNA methylation inheritance by the Dnmt1-including complexes during the cell cycle, Cell Div, vol.7, p.5, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00680687
Myc represses transcription through recruitment of DNA methyltransferase corepressor, EMBO J, vol.24, issue.2, pp.336-346, 2005. ,
Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation, Epigenetics, vol.4, issue.7, pp.487-499, 2009. ,
Epigenetic metalloenzymes, Curr. Med. Chem, vol.26, issue.15, pp.2748-2785, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-01885512
Epigenetic changes induced by curcumin and other natural compounds, Genes Nutr, vol.6, issue.2, pp.93-108, 2011. ,
Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells, Breast Cancer Res. Treat, vol.120, issue.3, pp.581-592, 2010. ,
First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies, Invest. New Drugs, vol.33, issue.5, pp.1048-1057, 2015. ,
Bromodomains as therapeutic targets, Expert Rev. Mol. Med, vol.13, p.29, 2011. ,
MG98, a second-generation DNMT1 inhibitor, in the treatment of advanced renal cell carcinoma, Cancer Invest, vol.30, issue.5, pp.415-421, 2012. ,
Procainamide is a specific inhibitor of DNA methyltransferase 1, J. Biol. Chem, vol.280, issue.49, pp.40749-40756, 2005. ,
, ? Identifies a selective DNMT1 inhibitor
Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells, Mol. Cancer Ther, vol.9, issue.11, pp.3015-3023, 2010. ,
The inhibition of the mammalian DNA methyltransferase 3a (Dnmt3a) by dietary black tea and coffee polyphenols, BMC Biochem, vol.12, p.16, 2011. ,
The selective HDAC6 inhibitor Nexturastat A induces apoptosis, overcomes drug resistance and inhibits tumor growth in multiple myeloma, Biosci. Rep, vol.39, issue.3, p.20181916, 2019. ,
The functional interactome landscape of the human histone deacetylase family, Mol. Syst. Biol, vol.9, p.672, 2013. ,
The HDAC interaction network, Mol. Syst. Biol, vol.9, p.671, 2013. ,
The TET2 interactors and their links to hematological malignancies, IUBMB Life, vol.67, issue.6, pp.438-445, 2015. ,
Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma, Clin. Epigenetics, vol.10, p.17, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01981717
Dnmt1/transcription factor interactions: an alternative mechanism of DNA methylation inheritance, Genes Cancer, vol.1, issue.5, pp.434-443, 2010. ,
DNMT3L interacts with transcription factors to target DNMT3L/DNMT3B to specific DNA sequences: role of the DNMT3L/DNMT3B/p65-NF?B complex in the (de-)methylation of TRAF1, Biochimie, vol.104, pp.36-49, 2014. ,
The role of epigenomics in personalized medicine, Expert Rev. Precis. Med. Drug Dev, vol.2, issue.1, pp.33-45, 2017. ,
Pharmacoepigenetics: an element of personalized therapy?, Expert Opin. Drug Metab. Toxicol, vol.13, issue.4, pp.387-398, 2017. ,
Epigenomics, pharmacoepigenomics, and personalized medicine in cervical cancer, Public Health Genomics, vol.20, issue.2, pp.100-115, 2017. ,
Protein-protein interaction modulators for epigenetic therapies, Adv. Protein Chem. Struct. Biol, vol.110, pp.65-84, 2018. ,
Supports the interest to target protein-protein interactions for the design of selective epidrugs ,
Astemizole arrests the proliferation of cancer cells by disrupting the EZH2-EED interaction of polycomb repressive complex 2, J. Med. Chem, vol.57, issue.22, pp.9512-9521, 2014. ,
Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion, Cancer Res, vol.73, issue.1, pp.235-245, 2013. ,
Disruption of STAT3-DNMT1 interaction by SH-I-14 induces re-expression of tumor suppressor genes and inhibits growth of triple-negative breast tumor, Oncotarget, vol.8, issue.48, pp.83457-83468, 2017. ,
,
Small molecule antagonists of the interaction between the histone deacetylase 6 zinc-finger domain and ubiquitin, J. Med. Chem, vol.60, issue.21, pp.9090-9096, 2017. ,
Controlled inhibition of methyltransferases using photoswitchable peptidomimetics: towards an epigenetic regulation of leukemia, Chem. Sci, vol.8, issue.6, pp.4612-4618, 2017. ,
Specific inhibition of DNMT3A/ISGF3? interaction increases the temozolomide efficiency to reduce tumor growth, Theranostics, vol.6, issue.11, pp.1988-1999, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01414173
,
Specific inhibition of DNMT1/CFP1 reduces cancer phenotypes and enhances chemotherapy effectiveness, Epigenomics, vol.6, issue.3, pp.267-275, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02478615
Specific inhibition of one DNMT1-including complex influences tumor initiation and progression, Clin. Epigenetics, vol.5, issue.1, p.9, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00851207
Epigenetic drug repositioning for Alzheimer's disease based on epigenetic targets in human interactome, J. Alzheimers Dis, vol.61, issue.1, pp.53-65, 2018. ,